Previous Close | 30.15 |
1-Year Change | 63.77% |
6-Months Change | -41.33% |
3-Months Change | -29.04% |
Moving Avg (50d) | 36.679 |
Moving Avg (200d) | 38.082 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.97B |
Beta (3-Years) | 1.48 |
Revenue Growth (ttm) | -2.44% |
Net Profit Margin (ttm) | -27.02% |
Return On Assets (ttm) | -22.18% |
EPS (ttm) | -3.23 |
PE Ratio (ttm) | -9.33 |
Dividend Yield | % |
Asset Description: | Tandem Diabetes Care, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-20 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
29.547 | 28.642 | 28.039 | 27.135 | 25.627 | 24.12 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Technology |
Country: | United States |
Tandem Diabetes Care is an American medical device manufacturer based in San Diego, California. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy. Wikipedia